Drug Type Small molecule drug |
Synonyms |
Target |
Action degraders |
Mechanism ERs degraders(Estrogen receptors degraders) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Unresectable Breast Carcinoma | Phase 2 | China | 12 Aug 2024 | |
ER-positive/HER2-negative Breast Cancer | Phase 2 | China | 20 Dec 2023 | |
Advanced breast cancer | Phase 1 | China | 17 Feb 2022 | |
Advanced cancer | IND Approval | China | 18 Oct 2024 |